Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 153.27
-0.013 %
$ 15.5 B
Market Cap
40.87
P/E
NBIX - ACCOUNTS PAYABLE
Accounts Payable NBIX - Neurocrine Biosciences, Inc.
109 M
LAST VALUE
45.42%
2 YEAR CAGR
51.16%
5 YEAR CAGR
101.03%
10 YEAR CAGR